43USSA1812
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 43USSA1812, covering 2025-06-26 to 2025-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Extension for 43USSA1812 [NA]
1 regulatory and trial event tracked for 43USSA1812, covering 2025-06-26 to 2025-06-26. Get the full timeline:
Most recent: Clinical Trial Update: Open Label Extension for 43USSA1812 [NA]